Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cancer|May 1, 1988
An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancerE T Creagan, J C Buckner, R G Hahn, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancerE T Creagan, S J Green, D L Ahmann, et al.
Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.
Oncology|January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumorsR T Eagan, E T Creagan, H F Bisel, et al.
Cancer|January 15, 1989
Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanomaD L Ahmann, E T Creagan, R G Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanomaR F Morton, E T Creagan, S A Cullinan, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cancer|May 1, 1988
An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancerE T Creagan, J C Buckner, R G Hahn, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancerE T Creagan, S J Green, D L Ahmann, et al.
Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.
Oncology|January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumorsR T Eagan, E T Creagan, H F Bisel, et al.
Cancer|January 15, 1989
Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanomaD L Ahmann, E T Creagan, R G Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanomaR F Morton, E T Creagan, S A Cullinan, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Pageof 12